Tags: Drug.

Ezetimibe/atorvastatin (brand name Liptruzet) is a cholesterol lowering combination drug. In the United States it was approved in May 2013 by the Food and Drug Administration for the treatment of elevated low-density lipoprotein (LDL) in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet.Some cardiologists opposed the approval because the combination reduced LDL cholesterol in a clinical trial it did not reduce heart disease.

Loading...

This page contains content from the copyrighted Wikipedia article "Ezetimibe/atorvastatin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.